Congressional Researchers Call Out FDA For Missing Deadline To Publish Cannabinoid List And Define Hemp ‘Containers’
Congressional researchers have identified that the FDA missed a legal deadline to publish a list of known cannabinoids and define hemp product containers, as federal hemp regulations are expected to change significantly later this year. The missed deadline stems from appropriations legislation signed by President Trump and is anticipated to substantially affect the existing hemp market.
Filed under Federal Action in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
Feds Finalize New Rule Allowing Some Hemp Products As Medicare Advantage Benefits
GOP Congressman Files Bill To Delay Federal Hemp Ban For Two More Years As Trump Calls For CBD Access
U.S. Senators developing new laws for THC and the Hemp industry
Minnesota cannabis: New rules mixing medical, recreational and hemp operations face mixed reviews
Minnesota Allows Hemp Businesses to Continue Using Out-of-State Testing Labs Until Next Year
US (MN): New rules mixing medical, recreational and hemp operations face mixed reviews
Stay current on Minnesota cannabis
Browse more federal action updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.